Coeliac Disease Trial, Recruiting NCT07716488 Sponsor: Alexandra Miriam Kiess Condition: Coeliac Disease
Back to Coeliac Disease

Coeliac Disease Trial, Recruiting

NCT07716488
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children and teenagers between the ages of 5 and 18 who are receiving ongoing treatment at the UKJ (University Hospital Jena) for a long-term health condition, such as a heart defect present from birth, inflammatory bowel disease, celiac disease, or a rheumatic disease

Who may not be able to join:

  • People where the patient or their parent(s) or legal guardian(s) have not given their agreement to participate in the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Alexandra M Kiess, MD, University Hospital Jena

Phone: 0049-3641-9329578

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Alexandra Miriam Kiess
Registry
ClinicalTrials.gov
Start date
1 August 2026
Est. completion
31 January 2027

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Prevalence of elevated lipid levels and familial hyperlipidemias in our sample of chronically ill children and adolescents

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov